An Electrically Stimulated CBD Infused Pain-Relieving Patch

Abstract

An electrically stimulated CBD infused pain-relieving patch that is placed on a human's skin that is used to relieve pain when it is connected to a controlled electrical current generating device. The electrically stimulated CBD infused pain-relieving patch comprises of a carrier that has at least one electrode, at least one conductive electrode sheet that is attached to the carrier, and a conductive gel that is placed on the electrode sheet. The conductive gel contains at least one analgesic that is selected from the group consisting of Menthol, CBD, Lidocaine or Capsaicin. The conductive gel has inactive ingredients.

Claims

1. An electrically stimulated CBD infused pain-relieving patch that is placed on a human's skin that is used to relieve pain when it is connected to a controlled electrical current generating device, the patch comprises of a carrier that has at least one electrode, at least one conductive electrode sheet that is attached to the carrier, and a conductive gel that is placed on the electrode sheet.

2. The electrically stimulated CBD infused pain-relieving patch that is placed on a human's skin that is used to relieve pain when it is connected to a controlled electrical current generating device of claim 2, wherein the conductive gel is comprised of at least one analgesic that is selected from the group consisting of a Menthol, a CBD, a Lidocaine or a Capsaicin.

3. The electrically stimulated CBD infused pain-relieving patch that is placed on a human's skin that is used to relieve pain when it is connected to a controlled electrical current generating device of claim 2, wherein the at least one analgesic comprises of the CBD that is in the range from about 0.001 percent to about 20.000 percent of the gel and the Lidocaine that is in the range from about 0.001 percent to about 10.000 percent of the gel.

4. The electrically stimulated CBD infused pain-relieving patch that is placed on a human's skin that is used to relieve pain when it is connected to a controlled electrical current generating device of claim 3, wherein the at least one analgesic comprises of the Menthol that is in the range from about 0.010 percent to about 20.000 percent of the gel.

5. The electrically stimulated CBD infused pain-relieving patch that is placed on a human's skin that is used to relieve pain when it is connected to a controlled electrical current generating device of claim 4, wherein the at least one analgesic comprises of the Capsaicin that is in the range from about 0.001 percent to about 8.000 percent of the gel.

6. The electrically stimulated CBD infused pain-relieving patch that is placed on a human's skin that is used to relieve pain when it is connected to a controlled electrical current generating device of claim 5, the gel comprises of a plurality of inactive ingredients.

7. The electrically stimulated CBD infused pain-relieving patch that is placed on a human's skin that is used to relieve pain when it is connected to a controlled electrical current generating device of claim 1, the gel comprises of a plurality of inactive ingredients.

Description

DRAWINGS

[0016] These and other features, aspects, and advantages of the present invention will become better understood with regards to the following description, appended claims, and drawings where:

[0017] FIG. 1 a photograph that shows an electrically stimulated CBD infused pain-relieving patch system that is placed on a human's skin that is used to relieve pain;

[0018] FIG. 2 a photograph that shows a TENS device connected to the pain-relieving patch of the present invention: and

[0019] FIG. 3 is a view of an embodiment of the present invention.

DETAILED DESCRIPTION

[0020] As seen in FIGS. 1-3, the present invention describes an electrically stimulated CBD infused pain-relieving patch 10 that is placed on a human's skin that is used to relieve pain. The pain-relieving patch 10 comprises of a carrier 30 that has at least one electrode 12, at least one conductive electrode sheet 32 that is attached to the carrier 30, and a conductive gel 34 that is placed on the electrode sheet 32. In use, the pain-relieving patch 10 is connected to a controlled electrical current generating device 20. The device can be either a TENS device, an interferential device or an EMS device.

[0021] The conductive gel 34 has at least one analgesic that is selected from the group consisting of a Menthol, a CBD, a Lidocaine or a Capsaicin. In a preferred embodiment, the at least one analgesic comprises of the CBD in the range from about 0.001 percent to about 20.000 percent of the gel and the Lidocaine in the range from about 0.001 percent to about 10.000 percent of the gel.

[0022] In another embodiment of the present invention, the at least one analgesic further comprises of the Menthol in the range from about 0.010 percent to about 20.000 percent of the gel.

[0023] In still another embodiment of the present invention, the at least one analgesic shall further comprise of the Capsaicin in the range from about 0.001 percent to about 8.000 percent of the gel.

[0024] The conductive gel of the present invention shall comprise of a plurality of inactive compounds. In a preferred embodiment, the plurality of inactive compounds shall be Water, Glycerin, Propylene Glycol, PVP, Sodium Polyacrylate, Methylparaben, Propylparaben, Aluminum Glycinate, Kaolin, Polyacrylic Acid, Polysorbate 80, Tartaric Acid, and/or Titanium Dioxide. Depending on the embodiment of the present invention, the inactive compounds shall be added to the conductive gel until a one hundred percent measurement is reached.

[0025] The patch is used by placing the patch on a user, connecting the patch to the controlled electrical generating device, powering the electrical generating device to deliver a charge. The pain-relieving patch can remain on a user's skin for a period of between eight to twelve hours. An Electrical Muscle Stimulation device can also be used to provide the electric current to the pain-relieving patch.

[0026] An advantage of the present invention is that it provides an electrically stimulated CBD infused pain-relieving patch that maximizes the release of a pain reliever onto a user's skin.

[0027] Another advantage of the present invention is that it provides an electrically stimulated CBD infused pain-relieving patch that treats pain.

[0028] Yet another advantage of the present invention is that it provides an electrically stimulated CBD infused pain-relieving patch that increases blood flow in treated areas.

[0029] Still another advantage of the present invention is that it provides an electrically stimulated CBD infused pain-relieving patch that relieves pain associated with arthritis.

[0030] While the inventor's above description contains many specificities, these should not be construed as limitations on the scope, but rather as an exemplification of several preferred embodiments thereof. Accordingly, the scope should not be determined by the embodiments illustrated, but by the appended claims and their legal equivalents.